Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Intensive BP Lowering May Not Reduce Risk of Recurrent Stroke

Publish date:: April 16, 2019

Key clinical point: Compared with standard treatment, intensive blood pressure reduction provides a nonsignificant reduction of recurrent stroke risk.

Major finding: The rate of recurrent stroke was 1.65% in the intensive treatment group and 2.26% in the standard treatment group.

Study details: A randomized, open-label trial of 1,263 patients with a history of stroke in the previous 3 years.

Disclosures: This study was sponsored by Biomedis International.

Citation:

Kitagawa K et al. ISC 2019, Abstract LB10.

This Week's Must Reads

Frequent soaks ease pediatric atopic dermatitis,

SZC passes extension test for hyperkalemia,

BCL11A-directed gene therapy advances in sickle cell disease,

Pimavanserin reduced dementia-related psychotic symptoms without affecting cognition,

Asthma exacerbation in pregnancy impacts moms, babies,

Must Reads in Cardiology

SZC passes extension test for hyperkalemia,

Intensive BP control reduced dementia but increased brain atrophy and hurt cognition,

Cardiac arrests peak with pollution in Japan,

Icosapent ethyl cost effective in REDUCE-IT analysis,

Statins in children cut long-term CVD risk in familial hypercholesterolemia,